Literature DB >> 11284762

Vitreoretinal surgery in Behçet's disease with severe ocular complications.

Y Ozertürk1, Y Bardak, M Durmuş.   

Abstract

PURPOSE: To investigate effects of vitreoretinal surgery in Behçet's disease. MATERIALS AND
METHOD: Vitreoretinal surgery was applied to 26 eyes of 21 patients with Behçet's disease. Preoperative and postoperative visual acuities, number and duration of attacks, anterior and posterior segment pathologies were evaluated.
RESULTS: The mean age of the patients was 33 years and female/male ratio was 6/15. The mean follow-up was 23 months. Visual acuity increased in 15 eyes (58%), did not change in 11 eyes (42%). In the postoperative period, there was a significant decrease in mean number of uveitis attacks compared to the preoperative period (p=0.001), as well as a significant decrease in the mean duration of uveitis attacks (p=0.001). In the postoperative follow-up, intravitreal haemorrhage in 2 eyes (8%), posterior subcapsular cataract in 5 eyes (19%) and corticonuclear cataract in 2 eyes (8%) were observed. Posterior capsular opacification (PCO) developed in 5 of 16 eyes (31%) having ECLE-IOL. CME continued in 3 eyes (12%).
CONCLUSION: Vitreoretinal surgery has favourable effect on the visual and anatomic prognosis in Behçet's patients with severe ocular complications.

Entities:  

Mesh:

Year:  2001        PMID: 11284762     DOI: 10.1034/j.1600-0420.2001.079002192.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

1.  Panuveitis complicated by an inflammatory retinal mass.

Authors:  Weiqiang Qiu; Huirong Zhang; Ziyuan Liu; Xuran Dong; Xuemin Li; Wei Wang
Journal:  J Ocul Biol Dis Infor       Date:  2013-01-10

Review 2.  [Adamantiades-Behcet's disease].

Authors:  L Krause
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.

Authors:  Lothar Krause; Andreas Altenburg; Nikolaos E Bechrakis; Gregor Willerding; Christos C Zouboulis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-13       Impact factor: 3.117

5.  Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report.

Authors:  Lothar Krause; Friedrich Hoffmann; Christos C Zouboulis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-09       Impact factor: 3.117

Review 6.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

7.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19

8.  Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study.

Authors:  Kazuichi Maruyama; Tohru Inaba; Sunao Sugita; Ryo Ichinohasama; Kenji Nagata; Shigeru Kinoshita; Manabu Mochizuki; Toru Nakazawa
Journal:  BMJ Open       Date:  2017-11-16       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.